SHORT MINI-FUTURE - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 18:53:21 20/06/2024 BST | ||
| 9.29 EUR | -1.90% |
|
| Current month | -0.32% | ||
| 1 month | +8.15% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 20/06/24 | 9.29 | -1.90% |
| 19/06/24 | 9.47 | +1.72% |
| 18/06/24 | 9.31 | +1.97% |
| 17/06/24 | 9.13 | +3.51% |
| 14/06/24 | 8.82 | +2.20% |
Delayed Quote Deutsche Boerse AG
Last update June 20, 2024 at 06:53 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VU8M9R |
| ISIN | DE000VU8M9R1 |
| Date issued | 15/06/2023 |
| Strike | 324.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.9 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.61 € |
|---|---|
| Lowest since issue | 1.73 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
225.6
USD
Average target price
284.6
USD
Spread / Average Target
+26.18%
- Stock Market
- Certificates
- Certificat
